In 2023, antiretroviral therapy coverage in France was estimated at approximately 87% of persons living with HIV. Forecast data suggests a steady increase in coverage over the next five years, with a projected rise to 95% by 2028. The anticipated year-on-year growth from 2024 to 2025 is approximately 2.25%, indicating a consistent commitment to improving access to therapy. The compound annual growth rate (CAGR) over the five-year forecast period is approximately 1.76%, reflecting a steady enhancement in coverage rates.
Future trends to watch for include potential advancements in HIV treatment technologies, government policies promoting broader access, and initiatives for increased awareness and testing, which could further boost therapy uptake and enhance the quality of life for those affected.
